Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses

被引:109
作者
Chao, C
Hergenhahn, M
Kaeser, MD
Wu, ZQ
Saito, S
Iggo, R
Hollstein, M
Appella, E
Xu, Y
机构
[1] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA
[2] Deutsch Krebsforschungszentrum, Dept Genet Alterat Carcinogenesis, D-69120 Heidelberg, Germany
[3] Swiss Inst Expt Canc Res, Oncogene Grp, CH-1066 Epalinges, Switzerland
[4] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1074/jbc.M306938200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Phosphorylation of mouse p53 at Ser(18) occurs after DNA damage. To determine the physiological roles of this phosphorylation event in p53-dependent DNA damage responses, a Ser(18) to Ala missense mutation was introduced into the germline of mice. Thymocytes and fibroblasts from the knock-in mice show reduced transactivation of many p53 target genes following DNA damage. p53 protein stabilization and DNA binding are similar in knock-in and wild type mice, but C-terminal acetylation was defective, consistent with a role for Ser(18) in the recruitment of transcriptional co-activators. The apoptotic response of knock-in thymocytes to ionizing radiation is intermediate between that of wild type and p53 null thymocytes. Despite impaired transcriptional and apoptotic responses, the knock-in mice are not prone to spontaneous tumorigenesis. This indicates that neither phosphorylation of p53 on Ser(18) by ATM nor a full transcriptional response is essential to prevent spontaneous tumor formation in mice.
引用
收藏
页码:41028 / 41033
页数:6
相关论文
共 30 条
[11]
Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15 [J].
Dumaz, N ;
Milne, DM ;
Meek, DW .
FEBS LETTERS, 1999, 463 (03) :312-316
[12]
Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment [J].
Espinosa, JM ;
Emerson, BM .
MOLECULAR CELL, 2001, 8 (01) :57-69
[13]
Mdm2 promotes the rapid degradation of p53 [J].
Haupt, Y ;
Maya, R ;
Kazaz, A ;
Oren, M .
NATURE, 1997, 387 (6630) :296-299
[14]
P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[15]
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 [J].
Honda, R ;
Tanaka, H ;
Yasuda, H .
FEBS LETTERS, 1997, 420 (01) :25-27
[16]
A transactivation-deficient mouse model provides insights into Trp53 regulation and function [J].
Jimenez, GS ;
Nister, M ;
Stommel, JM ;
Beeche, M ;
Barcarse, EA ;
Zhang, XQ ;
O'Gorman, S ;
Wahl, GM .
NATURE GENETICS, 2000, 26 (01) :37-43
[17]
Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo [J].
Kaeser, MD ;
Iggo, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :95-100
[18]
p53: Puzzle and paradigm [J].
Ko, LJ ;
Prives, C .
GENES & DEVELOPMENT, 1996, 10 (09) :1054-1072
[19]
Regulation of p53 stability by Mdm2 [J].
Kubbutat, MHG ;
Jones, SN ;
Vousden, KH .
NATURE, 1997, 387 (6630) :299-303
[20]
Phosphorylation of p53 serine 15 increases interaction with CBP [J].
Lambert, PF ;
Kashanchi, F ;
Radonovich, MF ;
Shiekhattar, R ;
Brady, JN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :33048-33053